Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
These include: Nausea Vomiting Diarrhea or constipation Stomach pain Fatigue Serious side effects and safety warnings Both liraglutide and semaglutide medications carry FDA warnings about the potential risk of thyroid C-cell tumors
Nevertheless, regulators have issued warnings after a rise in deaths from pancreatitis associated with GLP-1 use
High Purity & Quality Assurance All products come with complete documentation including COA (Certificate of Analysis), HPLC chromatogram, and Mass Spectrum
But for patients without easy access to lab work, it's a meaningful value-add that partially justifies the higher monthly cost
As of April 2026, CJC-1295 and Ipamorelin have been removed from the Food and Drug Administrations (FDA) Category 2 restricted list, with formal review of compounding eligibility scheduled for July 2026
Safety Profile: Clinical Evidence for Combined Use Published clinical trials examining GLP-1 medications in patients with hypothyroidism have not identified contraindications or serious drug interactions between semaglutide and levothyroxine
